INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Revenues	$ 2,752	$ 95	$ 2,847	$ 190
Cost of revenues	(97)	(4)	(100)	(7)
Gross profit	2,655	91	2,747	183
Operating Expenses:
Research and development expenses	(5,571)	(5,385)	(10,630)	(11,121)
Less participation by the Office of the Chief Scientist and other parties	234	506	1,165	2,205
Research and development expenses, net	(5,337)	(4,879)	(9,465)	(8,916)
General and administrative expenses	(1,546)	(1,513)	(3,033)	(3,191)
Operating loss	(4,228)	(6,301)	(9,751)	(11,924)
Financial income (expense), net	266	56	(87)	(232)
Net loss for the period	$ (3,962)	$ (6,245)	$ (9,838)	$ (12,156)
Loss per share:
Basic and diluted net loss per share	$ (0.05)	$ (0.09)	$ (0.12)	$ (0.17)
Weighted average number of shares used in computing basic and diluted net loss per share	79,370,673	70,070,509	79,066,675	69,610,528